Anika Therapeutics(ANIK) - 2024 Q3 - Quarterly Results
ANIKAnika Therapeutics(ANIK)2024-10-31 19:20

EXHIBIT 99.1 Anika Reports Third Quarter 2024 Financial Results Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management headwinds Strategy to focus on market leading OA Pain Management and high-growth Regenerative Solutions Company to categorize revenue into OEM Channel and Commercial Channel; Commercial Channel remains on track to achieve ~17% CAGR since 2021 with recent ...